Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
A prospective, randomized, placebo-controlled treatment trial to evaluate orally administered sodium butyrate (150 mg every 12 h for 12 weeks) or placebo in children with newly diagnosed Inflammatory bowel disease (IBD) (Crohn's disease (CD) or Ulcerative colitis (UC)) .
Primary outcome measures:
The difference in remission rate and disease activity between the two study groups assessed by PCDAI and PUCAI scores measured at 12 weeks.
Conclusion:
The 12-week supplementation with sodium butyrate, used as an additional therapy, was not effe…